文献速递临床试验与 GCP

FROSTBLOCK 试验:关节腔内皮质类固醇注射联合或不联合肩胛上神经阻滞治疗冻结肩的随机对照试验方案

The FROSTBLOCK trial: Protocol for a randomized controlled trial of intra-articular corticosteroid injection with or without suprascapular nerve block in frozen shoulder.
PubMed 文献 · Trials · 2025-09-29

FROSTBLOCK 是一项双臂、单中心、随机、平行组对照试验,将符合条件的冻结肩患者按 1:1 随机分配至长效肩胛上神经阻滞(SSNB)联合关节腔内皮质类固醇注射(IACI)组或安慰剂 SSNB 联合 IACI 组。主要终点为肩痛与功能障碍指数(SPADI)评分从基线至 3 个月的平均变化,次要结局包括生活质量、功能、疼痛、运动恐惧、工作状态、医疗服务使用及安全性评估,主要论文将基于基线至 12 个月的重复测量数据。

要点

  • 冻结肩影响 2% 至 5% 的人群,糖尿病患者及甲状腺问题者发病率更高。
  • 研究比较长效 SSNB 联合 IACI 与安慰剂 SSNB 联合 IACI 在冻结肩患者中的疗效差异。
  • 主要终点为 SPADI 评分从基线至 3 个月的平均变化。

核心结论

  • 本研究旨在确定在关节腔内皮质类固醇注射基础上加用长效肩胛上神经阻滞相比安慰剂肩胛上神经阻滞对冻结肩患者疼痛缓解和功能改善的额外效应。
  • 本研究还旨在确定哪些患者从这些治疗中获益最大。
  • 本研究可能改变冻结肩疼痛期患者的标准治疗。

研究设计与样本

  • 双臂、单中心、随机、平行组对照试验。
  • 符合条件的患者按 1:1 随机分配至长效 SSNB 联合 IACI 组或安慰剂 SSNB 联合 IACI 组。
  • 主要论文将基于基线至 12 个月的重复测量数据。
  • 试验注册于 ClinicalTrials.gov,注册号 NCT06229964,注册日期 2024 年 1 月 9 日。

主要发现

  • 主要终点为 SPADI 评分从基线至 3 个月的平均变化。
  • 次要结局评估生活质量、功能、疼痛(采用数字疼痛评定量表测量)、运动恐惧、工作状态、医疗服务使用及安全性评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frozen shoulder is a challenging musculoskeletal disorder, affecting between 2 and 5% of people, with a higher incidence among those with diabetes and thyroid issues. This condition can persist for years and can be very demanding for both patients and healthcare providers due to the intense pain and restricted shoulder movement. Literature shows that intra-articular corticoid injection (IACI) and suprascapular nerve block (SSNB) can improve pain and range of motion in these patients. The objective of this study is to investigate if there is any significant difference in pain reduction and functional recovery when treated with a combination of gleno-humeral IACI and SSNB compared to a gleno-humeral IACI paired with a placebo SSNB. METHODS: A two-arm, single-centre, randomized, parallel-group controlled trial will be conducted. Eligible patients will be randomly assigned (1:1 allocation) to long-acting SSNB + IACI and placebo SSNB + IACI. The primary endpoint is the mean change from baseline to 3 months in the Shoulder Pain and Disability Index (SPADI) score. Secondary outcomes will evaluate quality of life, functionality, pain (measured by a Numeric Pain Rating Scale), kinesiophobia, work status, health care service, and a safety assessment. The main paper will be based on the repeated measures collected up to 12 months from baseline. DISCUSSION: The aim of this study is to determine the additional effect on pain relief and functional improvement in frozen shoulder patients when a long-acting SSNB is administered, compared to a placebo SSNB, in combination with an intra-articular corticosteroid injection. Additionally, we will aim to determine which patients benefit most from these treatments. This study could lead to a change in the standard of care for patients in the painful phase of frozen shoulder. TRIAL REGISTRATION: ClinicalTrials.gov NCT06229964. Registered on 9 January 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Schiltz M, Croes J, van Brabander L, et al. The FROSTBLOCK trial: Protocol for a randomized controlled trial of intra-articular corticosteroid injection with or without suprascapular nerve block in frozen shoulder. Trials. 2025. PMID: 41023761. doi:10.1186/s13063-025-09123-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。